192 related articles for article (PubMed ID: 2910134)
1. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine.
Hobbhahn J; Conzen PF; Zenker B; Goetz AE; Peter K; Brendel W
Anesth Analg; 1988 Mar; 67(3):253-60. PubMed ID: 3125765
[TBL] [Abstract][Full Text] [Related]
3. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
Nuttall GA; Murray MJ; Bowie EJ
Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742
[TBL] [Abstract][Full Text] [Related]
4. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
Schumacher WA; Heran CL; Ogletree ML
Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
[TBL] [Abstract][Full Text] [Related]
5. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
Stefaniszyn HJ; Novick RJ; Salerno TA
J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
[TBL] [Abstract][Full Text] [Related]
6. Heparin-protamine reactions in pigs: role of oxygen-derived free radicals.
Vollmar B; Conzen PF; Habazettl H; Yekebas E; Peter K
J Appl Physiol (1985); 1993 May; 74(5):2412-20. PubMed ID: 8335575
[TBL] [Abstract][Full Text] [Related]
7. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
Rogers K; Milne B; Salerno TA
J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
[TBL] [Abstract][Full Text] [Related]
9. Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism.
Ghuysen A; Lambermont B; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Magis D; Hanson J; Segers P; D'Orio V
J Pharmacol Exp Ther; 2004 Sep; 310(3):964-72. PubMed ID: 15121765
[TBL] [Abstract][Full Text] [Related]
10. Absence of prostaglandin changes associated with protamine administration in patients with pulmonary hypertension.
Konstadt SN; Thys DM; Kong D; Mindich BP; Watkins WD
J Cardiothorac Anesth; 1987 Oct; 1(5):388-91. PubMed ID: 2979108
[TBL] [Abstract][Full Text] [Related]
11. Effect of leukopenia on pulmonary hypertension after heparin-protamine in pigs.
Habazettl H; Conzen PF; Vollmar B; Yekebas E; Peter K
J Appl Physiol (1985); 1992 Jul; 73(1):44-9. PubMed ID: 1506397
[TBL] [Abstract][Full Text] [Related]
12. [The effects of thromboxane receptor antagonist on hemodynamic responses after neutralization of heparin by protamine].
Yoshioka M; Wakamatsu M; Kuro M; Okumura F
Masui; 1991 Jun; 40(6):918-22. PubMed ID: 1875538
[TBL] [Abstract][Full Text] [Related]
13. Heparin-protamine complexes cause pulmonary hypertension in goats.
Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M
Anesthesiology; 1995 Oct; 83(4):786-91. PubMed ID: 7574058
[TBL] [Abstract][Full Text] [Related]
14. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
Morel DR; Costabella PM; Pittet JF
Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
[TBL] [Abstract][Full Text] [Related]
15. [Cellular mechanisms of pulmonary vasoconstriction in an experimental model of protamine reversal of heparin].
Montalescot G
Arch Mal Coeur Vaiss; 1990 Apr; 83(4):555-60. PubMed ID: 2111678
[TBL] [Abstract][Full Text] [Related]
16. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb.
Kurrek MM; Winkler M; Robinson DR; Zapol WM
Anesthesiology; 1995 Jan; 82(1):183-7; discussion 31A. PubMed ID: 7832299
[TBL] [Abstract][Full Text] [Related]
17. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension after heparin-protamine: roles of left-sided infusion, histamine, and platelet-activating factor.
Habazettl H; Conzen PF; Vollmar B; Yekebas E; Gutmann R; Hobbhahn J; Brendel W; Peter K
Anesth Analg; 1990 Dec; 71(6):637-44. PubMed ID: 2240637
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep.
Montalescot G; Lowenstein E; Ogletree ML; Greene EM; Robinson DR; Hartl K; Zapol WM
Circulation; 1990 Nov; 82(5):1765-77. PubMed ID: 2146041
[TBL] [Abstract][Full Text] [Related]
20. Effects of a thromboxane receptor antagonist (NT-126) and a thromboxane synthase inhibitor (OKY-O46) on protamine-induced circulatory changes in dogs.
Mizutani T; Takahashi S; Kihara S; Toyooka H
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):687-92. PubMed ID: 11139110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]